COMET THERAPEUTICS
CoEnzyme is a developer of therapies designed to treat orphan neurological disorders. The company develops a treatment to restore dysregulated CoEnzyme A metabolism through its CoEnzyme metabolism platform, enabling physicians to address the profound unmet medical needs.
COMET THERAPEUTICS
Industry:
Biotechnology Health Care Wellness
Founded:
2018-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.comettherapeutics.com
Total Employee:
1+
Status:
Active
Total Funding:
28.5 M USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
Hale Therapeutics
Hale Therapeutics, a Philadelphia firm developing a nicotine vaporizer designed to wean smokers and vapers off of nicotine.
NeuraLight
NeuraLight is a developer of neurology software designed to help patients affected by neurological disorders.
Neurogene
Neurogene is a developer of genetic medicines intended to improve patient outcomes for neurological disorders.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Inkef
Inkef investment in Series A - Comet Therapeutics
Canaan Partners
Canaan Partners investment in Series A - Comet Therapeutics
Sofinnova Partners
Sofinnova Partners investment in Series A - Comet Therapeutics
Mission BioCapital
Mission BioCapital investment in Series A - Comet Therapeutics
Official Site Inspections
http://www.comettherapeutics.com
- Host name: 199.59.243.227
- IP address: 199.59.243.227
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Comet Therapeutics"
Comet Therapeutics - Crunchbase Company Profile & Funding
When was the last funding round for Comet Therapeutics? Comet Therapeutics closed its last funding round on Jun 19, 2019 from a Series A round. Who are Comet Therapeutics 's โฆSee details»
Comet Therapeutics Overview | SignalHire Company Profile
Organization Website: comettherapeutics.com : Social Links: Comet Therapeutics industries Biotech: Headquarters Location: Cambridge, MA, 02139 US Cambridge, MA, 02139 US : โฆSee details»
Comet Therapeutics Company Profile - Office Locations ... - Craft
Comet Therapeutics focuses on the development of a portfolio of drug candidates that centers around efforts to re-engineer CoEnzyme-A (CoA). Its platform has numerous applications โฆSee details»
Comet Therapeutics, Inc. in Cambridge, Massachusetts - EIN TaxId
Comet Therapeutics, Inc. is a corporation in Cambridge, Massachusetts. The employer identification number (EIN) for Comet Therapeutics, Inc. is 384090565. EIN for organizations โฆSee details»
Comet Therapeutics Company Profile 2024: Valuation, Investors ...
Comet Therapeutics General Information Description. Developer of cellular therapies intended to treat neurological disorders. The company's therapies offer a treatment to restore โฆSee details»
Comet Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Comet Therapeutics, Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Comet Therapeutics - VentureRadar
Comet Therapeutics is the leader in CoEnzyme A (CoA) science and intermediate metabolism. Our proprietary CoMET? Platform is the foundation of a growing pipeline of next-generation โฆSee details»
Comet Therapeutics - Canaan
Comet Therapeutics. Comet is developing small molecule therapeutics with an initial focus on rare genetic diseases and inborn errors of metabolism, helping address defects in the bodyโs ability โฆSee details»
Comet Therapeutics - Contacts, Employees, Board Members
Organization. Comet Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Comet Therapeutics has 6 โฆSee details»
Comet Therapeutics, Inc. Asset Profile | Preqin
Founded in 2018 and based in Massachusetts, US, Comet Therapeutics, Inc. develops CoEnzyme Metabolism, a platform that addresses the metabolism of fatty acid...See details»
Comet Therapeutics | CipherBio
Explore Comet Therapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Comet Therapeutics - Funding, Financials, Valuation & Investors
Comet Therapeutics is a developer of therapies designed to treat orphan neurological disorders. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... How much โฆSee details»
Comet Therapeutics, Inc. (Comet Therapeutics, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธ โฆ
Under the terms of the agreement, VectivBio will acquire Comet Therapeutics in exchange for equity and cash, as well as additional milestone payments that were not disclosed. โThe โฆSee details»
VectivBio Announces Closing of Comet Therapeutics Acquisition
Sep 21, 2021 - Proprietary CoMET platform aims to treat severe rare Inherited Metabolic Diseases -BASEL, Switzerland, Sept. 21, 2021 (GLOBE NEWSWIRE) -- VectivBio Holding AG โฆSee details»
Comet Therapeutics Raises $28.5 Million Series A Financing
Jun 19, 2019 Comet Therapeutics, a company built around the unique ability to re-engineer Coenzyme A (CoA)-related metabolism, has raised $28.5 million in Series A funding to โฆSee details»
Compass Therapeutics
We are developing next generation antibodies into transformative cancer therapies that improve patientsโ lives. Weโre leveraging our understanding of the tumor microenvironment to develop โฆSee details»
VectivBio acquires Comet Therapeutics - 2021-08-31 - Crunchbase
Aug 31, 2021 Comet Therapeutics Comet Therapeutics is a developer of therapies designed to treat orphan neurological disorders. Acquiring Organization: VectivBio VectivBio is a โฆSee details»
Home - ShapeTX
We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. Shape TX combines โฆSee details»
Apogee Therapeutics | Best-in-Class Therapies for Immunological โฆ
Apogee Therapeutics is a clinical stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest inflammatory and immunology โฆSee details»
Home - Hoth Therapeutics
About Hoth Therapeutics. At Hoth Therapeutics, we strive to develop innovative, impactful, and ground-breaking treatments with a goal to improve patient quality of life.See details»